Midazolam 1 mg/ml solution for injection in pre-filled syringe
Authorisation PA1968/017/001 · Laboratoire Aguettant
- Licence holder
- Laboratoire Aguettant (all products →)
- Active substance
- Midazolam
- Clinical trials
- 74 clinical trials →
- Dosage form
- Solution for injection in pre-filled syringe
- Routes of administration
- Intramuscular use, Intravenous use
- ATC code
- N05CD08
- First authorised
- 02/08/2024
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Hybrid application (Article 10(3) of Directive No 2001/83/EC)
Midazolam: supply and approvals
29 authorised products on the HPRA list contain Midazolam. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- Buccolam: Shortage resolved, first published 25 Apr 2014
- US shortage (FDA)
- Midazolam Hydrochloride Injection: in shortage, updated 18 Nov 2026
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 2 years (since 2 August 2024). The HPRA list marks it as marketed in Ireland.
Other medicines with Midazolam in Ireland
22 other products on the HPRA list contain Midazolam, from 7 licence holders; 10 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Midazolam 1 mg/ml Solution for Injection or Infusion | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Midazolam 1 mg/ml solution for injection/infusion | Laboratoire Aguettant | National authorisation (PA) | Marketed |
| Midazolam 2 mg/ml Solution for injection or infusion | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Midazolam 5 mg/ml Solution for injection or infusion | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Midazolam 5 mg/ml solution for injection/infusion | Laboratoire Aguettant | National authorisation (PA) | Marketed |
| Midazolam Rowa 10 mg oromucosal solution | Rowa Pharmaceuticals Limited, | National authorisation (PA) | Marketed |
| Midazolam Rowa 2.5 mg oromucosal solution | Rowa Pharmaceuticals Limited, | National authorisation (PA) | Marketed |
| Midazolam Rowa 5 mg oromucosal solution | Rowa Pharmaceuticals Limited, | National authorisation (PA) | Marketed |
| Midazolam Rowa 7.5 mg oromucosal solution | Rowa Pharmaceuticals Limited, | National authorisation (PA) | Marketed |
| Ozalin 2 mg/ml oral solution in single-dose container | Istituto Gentili S.r.l. | National authorisation (PA) | Marketed |
| BUCCOLAM 10 mg oromucosal solution | Laboratorios Lesvi, S.L. | Centralised EU authorisation | Not stated |
| BUCCOLAM 2.5 mg oromucosal solution | Laboratorios Lesvi, S.L. | Centralised EU authorisation | Not stated |
The licence holder
Laboratoire Aguettant holds 33 products on the HPRA list, with 27 different active substances; 18 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.